NIAID-funded study could offset harsh effects of antibiotics.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the procedure were randomly assigned into two groups: one group received standard care and the other received auto-FMT. The researchers found that auto-FMT resulted in the recovery of beneficial gut bacteria to near baseline levels within days, thus restoring patients’ digestive, immune and other essential functions. With standard care, beneficial bacteria typically take many weeks to recover from antibiotic treatment, leaving patients at risk of other infectious diseases, including Clostridium difficile.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, provided funding for part of the project. The study report appears in Science Translational Medicine.
“This important study suggests that clinical intervention using auto-FMT can safely reverse the disruptive effects of broad-spectrum antibiotic treatment,” says NIAID Director Anthony S. Fauci, M.D. “If validated in larger studies, this approach may prove to be a relatively simple way to quickly restore a person’s healthy microbiome following intensive antimicrobial therapy.”
Allogenic hematopoietic cell transplantation involves a donor — often but not exclusively a family member — who gives the recipient stem cells that re-establish bone marrow production of blood cells and immune function to combat cancer. Antibiotics are essential to prevent bacterial infections in stem cell recipients. However, antibiotics also destroy beneficial bacteria that enhance immune function and resistance to infection. The loss of beneficial bacteria increases the risk of certain life-threatening infectious diseases and graft-versus-host disease (GVHD).
The study involved cancer patients who provided their own fecal sample, which was frozen and stored prior to their cell transplantation procedure. Weeks later, when physicians confirmed that the transplanted cells were growing, they assessed the status of the patients’ beneficial gut bacteria. The first 25 patients who lacked known beneficial bacteria were enrolled into the study and randomly assigned to the different treatment groups: 14 received auto-FMT by enema and 11 received standard-of-care.
The patients who received auto-FMT consistently regained bacterial diversity, composition and function; recovery of beneficial bacteria in the 11 control patients was delayed.
The researchers are continuing to monitor the study patients to determine if auto-FMT improves patient outcomes, such as the incidence and severity of bacterial, viral and fungal infections and the incidence and severity of GVHD. Whether FMT from a healthy donor would be as beneficial as the patient’s own fecal sample at restoring beneficial bacteria remains to be studied.
The Latest on: Fecal microbiota transplantation
via Google News
The Latest on: Fecal microbiota transplantation
- Gut Microbiome Shifts Synchronize Panda Biorhythm to Bamboo Dieton January 19, 2022 at 4:00 am
Giant pandas stay chubby and healthy on a diet consisting solely of bamboo shoots, leaves and stems. A new study shows butyrate synthesized by the panda’s gut microbiota during shoot-eating season ...
- Panda poo reveals key to staying chubbyon January 18, 2022 at 8:12 am
Panda poo reveals key to staying chubby A seasonal dietary shift from bamboo leaves to bamboo shoots may help giant pandas stay chubby despite bamboo being a low-fat food. Researchers in China analyse ...
- A giant panda’s gut bacteria help it remain chubby while on a bamboo dieton January 18, 2022 at 8:03 am
The giant panda feeds exclusively on fibrous bamboo, yet they still manage to stay chubby and healthy. In a study published January 18 in the journal Cell Reports, researchers reveal that shifts in ...
- Microbial characteristics of COVID-19on January 13, 2022 at 8:10 am
To better understand how the disease progresses, a recent paper in the journal Frontiers in Medicine discusses the role of the human microbiota in this condition.
- In Preterm Pigs, The Effect Of Fecal Microbiota Transplantation Is Antagonized By Oral Broad-Spectrum Antibioticson January 13, 2022 at 4:48 am
Intravenous antibiotics (AB) are given to NEC patients to avert sepsis, despite enteral AB being more implicit but is hardly used as there is fear of AB resistance. Fecal microbiota transplantation ...
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantationon January 12, 2022 at 4:00 pm
The microbiota composition of fecal samples obtained from patients who were undergoing allogeneic hematopoietic-cell transplantation at four centers was profiled by means of 16S ribosomal RNA gene ...
- C. Diff Infection: Patient Access to Fecal Microbiota Transplanton January 4, 2022 at 6:20 am
11: Challenges in the Management of C. Diff Infection EP. 12: An Overview of Fecal Microbiota Transplant Use in C. Diff Infection Neil Minkoff, MD: Let me ask a question to the whole group.
- Practical Advice on Novel Fecal Microbiota Transplantation in CDIon January 3, 2022 at 6:20 am
And the modes of delivery are both easier than what we would typically do with an FMT [fecal microbiota transplantation], which is basically preparing someone for a procedure, whether it’s an ...
- Addressing the Barriers to Fecal Microbiota Transplantation in CDIon December 27, 2021 at 6:00 am
Experts reflect on the barriers to utilizing fecal microbiota transplantation therapy in Clostridioides difficile infection. EP. 1: C Difficile Infection: The Importance of the Gut Microbiome EP. 2: C ...
via Bing News